Daily Archives: September 22, 2008

Bristol-Myers Squibb to Commence Cash Tender Offer for ImClone Systems at $62.00 per share

NEW YORK, September 22, 2008 – Bristol-Myers Squibb Company (NYSE: BMY) today announced that it is increasing its initial offer for ImClone Systems Incorporated (NASDAQ: IMCL) and intends to commence a tender offer for the currently outstanding shares of common … Continue reading

Posted in Business/Industry News | Comments Off

Gilead Receives Complete Response Letter from FDA for Aztreonam Lysine for Inhalation, an Investigational Treatment for Cystic Fibrosis

Since Complete Response Letters (CRLs) have become the fashion for CDER after August 11, I have tried to make it a point to see how different companies respond to the receipt of such a letter in public communications.  As I … Continue reading

Posted in Complete Response Letters | 1 Comment